id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-E-2528-0003,FDA,FDA-2016-E-2528,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-09-26T04:00:00Z,2016,9,2016-09-26T04:00:00Z,,2016-09-26T16:15:46Z,,0,0,0900006482267dd3
FDA-2016-E-2528-0002,FDA,FDA-2016-E-2528,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-08-24T04:00:00Z,2016,8,2016-08-24T04:00:00Z,,2016-08-24T18:56:40Z,,0,0,0900006482198ba6
FDA-2016-E-2528-0001,FDA,FDA-2016-E-2528,"Patent Extension Application from Harness, Dickey & Pierce P.L.C. (on behalf of UCB Biopharma SPRL)",Other,Application,2016-08-24T04:00:00Z,2016,8,2016-08-24T04:00:00Z,,2016-08-24T18:50:04Z,,0,0,0900006482198ba2